FDA Expecting 43% Increase In ANDA Submissions For FY 2005
FDA's Office of Generic Drugs expects to receive 806 abbreviated new drug applications in fiscal year 2005, representing a 43% increase over the 563 received in FY 2004
FDA's Office of Generic Drugs expects to receive 806 abbreviated new drug applications in fiscal year 2005, representing a 43% increase over the 563 received in FY 2004